Biohit Oyj (Finland) Today
| BIOBV Stock | EUR 2.33 0.02 0.87% |
Performance4 of 100
| Odds Of DistressLess than 41
|
Biohit Oyj is trading at 2.33 as of the 26th of December 2024. This is a 0.87 percent increase since the beginning of the trading day. The stock's open price was 2.31. Biohit Oyj has about a 41 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 26th of November 2024 and ending today, the 26th of December 2024. Click here to learn more.
Biohit Oyj, a biotechnology company, produces diagnostic tests and analysis systems for use in research institutions and healthcare industries worldwide. The company was founded in 1988 and is headquartered in Helsinki, Finland. Biohit Oyj operates under Healthcare Services classification in Finland and is traded on Helsinki Exchange. The company has 12.07 M outstanding shares. More on Biohit Oyj B
Moving against Biohit Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biohit Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biohit Oyj's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biohit Oyj or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Health Care Equipment & Supplies, Biotechnology, Healthcare (View all Sectors) |
Biohit Oyj B (BIOBV) is traded on Helsinki Exchange in Finland and employs 44 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 30.69 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biohit Oyj's market, we take the total number of its shares issued and multiply it by Biohit Oyj's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biohit Oyj B operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 12.07 M outstanding shares.
Biohit Oyj B has accumulated about 9.38 M in cash with (444 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63.
Check Biohit Oyj Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Biohit Oyj B is €30.69 Million. Biohit Oyj B retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Biohit Ownership Details
Biohit Oyj B Risk Profiles
Although Biohit Oyj's alpha and beta are two of the key measurements used to evaluate Biohit Oyj's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.7 | |||
| Semi Deviation | 1.78 | |||
| Standard Deviation | 2.22 | |||
| Variance | 4.93 |
Biohit Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biohit Oyj without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Biohit Oyj Corporate Management
Elected by the shareholders, the Biohit Oyj's board of directors comprises two types of representatives: Biohit Oyj inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biohit. The board's role is to monitor Biohit Oyj's management team and ensure that shareholders' interests are well served. Biohit Oyj's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biohit Oyj's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Panu Hendolin | Head of Research and Development, Member of the Management Team | Profile | |
| Jussi Hahtela | Chief Officer | Profile | |
| Yulia Kubacheva | Head Russia | Profile | |
| Jussi Sorvo | Chief Officer | Profile | |
| Pr MD | Deputy Founder | Profile |
Other Information on Investing in Biohit Stock
Biohit Oyj financial ratios help investors to determine whether Biohit Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biohit with respect to the benefits of owning Biohit Oyj security.